Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing
Proceeds will be Used to Accelerate Advancement of Pipeline of Multispecific Antibodies in Oncology WAEDENSWIL, Switzerland--(BUSINESS WIRE)--Numab Therapeutics AG, a...
Proceeds will be Used to Accelerate Advancement of Pipeline of Multispecific Antibodies in Oncology WAEDENSWIL, Switzerland--(BUSINESS WIRE)--Numab Therapeutics AG, a...